Yesterday, the Drug Enforcement Administration (DEA) near-noticed a hearing for its marijuana rescheduling proposal. The hearing would begin on December 2, 2024 at 9 a.m. ET, and may span multiple days or even weeks. The announcement came via an unpublished “notice of hearing on proposed rulemaking” (NOH). The final NOH is set for publication this
Whether you support them or not, intoxicating hemp products are probably not going to be around for much longer in their current form. States, municipalities, and even the federal government have begun a clampdown on these products. In no particular order, I’ll address a few reasons why the back half of 2024 will be a
Kamala Harris is a heavy favorite for Democratic Presidential nominee, now that Joe Biden has dropped out of the race and endorsed her. This means we should re-open our short series on the 2024 Presidential candidates and marijuana. I thought we were done with this stuff. We can trot out some deep cuts with Kamala
On January 1, 2024, the federal Corporate Transparency Act (CTA) took effect. The CTA requires a host of both domestic and foreign entities to disclose their beneficial ownership to the Treasury’s Financial Crimes Enforcement Network (FinCEN). Compliance with the CTA is required for all businesses, including those in the cannabis industry. In this post, I’ll overview
Last week, the US Supreme Court decided its most recent Second Amendment case, United States v. Rahimi. Earlier this month, SCOTUS decided Garland v. Cargill, which could also spell changes for the cannabis industry later down the road. I wrote about the Rahimi case in earlier posts, as the outcome of the case could have affected
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. The letters typically come from the desk of Terrence L. Boos, Ph.D.,
Sometimes I’ll write about cannabis banking when I’m working on a project for a bank or credit union, but newsworthy developments on cannabis banking seldom seem to drop. Yesterday, however, we had a development worth covering: a Congressional Subcommittee added cannabis banking protections to a critical government spending bill. A GOP-chaired Subcommittee, no less. Marijuana
At some point in the last few years, people seemed to realize that getting a cannabis (marijuana) license is not cheap or easy, and that it’s a whole lot easier to sell intoxicating cannabinoid products. You’ve probably read some of our posts on like THCA or delta-8 products, for example. Another extremely popular alternative has been hemp THC
For years, people have tried to decipher the incredibly poorly worded (I can’t stress this enough) language in the 2018 Farm Bill and what it means for intoxicating hemp products like THCA products or delta-8. In the last week or so, there’s been a lot of bad news for the intoxicating hemp products industry. Let’s take
California‘s cannabis industry suffers from a seemingly unending list of problems: high taxes, prohibitionist cities, a related lack of retail licenses and oversupply of non-retail licenses, a monster illegal market with no end in sight, burdensome and often senseless regulations, and so on. Unfortunately, rescheduling won’t solve most of these problems–at least not directly. Today
